FDA panel backs first-of-a-kind COVID-19 pill from Merck

A panel of US health advisers narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorisation of the first drug that Americans could take at home to treat the virus.

PTI

December 01, 2021 / 07:51 IST

Story continues below Advertisement

Aurobindo Pharma | Life Insurance Corporation of India bought 79,000 equity shares in the company via open market transaction on November 24, increasing shareholding to 5.01 percent from 4.99 percent earlier.

A panel of US health advisers narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorisation of the first drug that Americans could take at home to treat the virus.

PTI

first published: Dec 1, 2021 07:51 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

FDA panel backs first-of-a-kind COVID-19 pill from Merck

A panel of US health advisers narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorisation of the first drug that Americans could take at home to treat the virus.

Trending Topics

News

Markets

Personal Finance

Mutual Funds

Tools

Community

Network 18 Sites

Quick Links